Shared genomic architecture between COVID-19 severity and numerous clinical and physiologic parameters revealed by LD score regression analysis

[1]  P. Tepasse,et al.  Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis , 2021, Viruses.

[2]  Q. Ostrom,et al.  The shared genetic architecture between epidemiological and behavioral traits with lung cancer , 2021, Scientific Reports.

[3]  Mattia G. Bergomi,et al.  Mapping the human genetic architecture of COVID-19 , 2021, Nature.

[4]  M. Fobker,et al.  Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis , 2021, Nutrients.

[5]  Y. Kuo,et al.  Smoking and risk of COVID-19 hospitalization , 2021, Respiratory Medicine.

[6]  C. Amos,et al.  The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies , 2021, Cancer Epidemiology, Biomarkers & Prevention.

[7]  S. Shete,et al.  Partitioned glioma heritability shows subtype-specific enrichment in immune cells. , 2021, Neuro-oncology.

[8]  T. Spector,et al.  Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people , 2021, Thorax.

[9]  L. Wain,et al.  Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity , 2020, EBioMedicine.

[10]  R. Romero-Ortuño,et al.  The relationship between the severity and mortality of SARS-CoV-2 infection and 25-hydroxyvitamin D concentration - a metaanalysis. , 2021, Advances in respiratory medicine.

[11]  J. Low,et al.  Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) , 2020, Nutrition.

[12]  S. Mutalik,et al.  Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review , 2020, Life Sciences.

[13]  R. Busse,et al.  Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study , 2020, The Lancet Respiratory Medicine.

[14]  S. Larsson,et al.  Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants , 2020, PLoS medicine.

[15]  J. Erdmann,et al.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure , 2020, The New England journal of medicine.

[16]  The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic , 2020, European Journal of Human Genetics.

[17]  Michael Roth,et al.  Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? , 2020, The Lancet Respiratory Medicine.

[18]  N. Wray,et al.  Genetic correlations of polygenic disease traits: from theory to practice , 2019, Nature Reviews Genetics.

[19]  D. Levinson,et al.  Genetic Correlation Profile of Schizophrenia Mirrors Epidemiological Results and Suggests Link Between Polygenic and Rare Variant (22q11.2) Cases of Schizophrenia , 2017, Schizophrenia bulletin.

[20]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[21]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[22]  M. Traber.  Mechanisms for the prevention of vitamin E excess , 2013, Journal of Lipid Research.

[23]  A. Janssens,et al.  Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities , 2011, European Journal of Human Genetics.

[24]  A. Cambon-Thomsen,et al.  Background Document to the ESHG recommendations on genetic testing and common disorders , 2011 .

[25]  L. Senelick.  It (review) , 2008 .

[26]  L. Perlemuter.  [From theory to practice]. , 1997, Soins. Psychiatrie.